Led by renowned researcher Dr. René Roy, Glycovax Pharma has developed an advanced family of technology platforms in the field of nano-medicine. Their goal is to cure various types of cancers and rare diseases with more effective treatments, reduce the side effects of therapeutics, prevent the development of common cancers through synthetic vaccines, and facilitate the production of high-quality synthetic drugs. Co-founded by Koranex Capital, Glycovax Pharma benefits from their network and expertise in creating innovative drugs and therapies using medical nanotechnology, with a focus on treating cancers and other diseases.